Disarming a pathogen with programmable phage-derived particles.

Programmable phage-derived particles effectively target and eliminate Escherichia coli producing Shiga toxin, offering a novel therapeutic approach.

• Why it matters: Infections with Shiga toxin-producing E. coli (STEC) are difficult to treat because antibiotics can trigger toxin release, worsening patient outcomes. Addressing this gap could improve treatment safety and efficacy.
• What they did: Galtier et al. designed phage-derived particles with customizable cell targeting, genetic payloads, and CRISPR guide RNAs to specifically destroy stx genes and kill STEC in animal models.
• The result: This approach successfully neutralizes the toxin-producing bacteria, paving the way for targeted therapies that prevent toxin release and improve infection management.